← Product Code [JWH](/submissions/OR/subpart-d%E2%80%94prosthetic-devices/JWH) · K183596

# Klassic Knee System - Klassic Knee PS-Post Femur; Klassic Knee Tibial Insert, PS-Post, Std Poly; Klassic Knee Tibial Insert, PS-Post, E-Link Poly (K183596)

_Total Joint Orthopedics, Inc. · JWH · Mar 29, 2019 · Orthopedic · SESE_

**Canonical URL:** https://fda.innolitics.com/submissions/OR/subpart-d%E2%80%94prosthetic-devices/JWH/K183596

## Device Facts

- **Applicant:** Total Joint Orthopedics, Inc.
- **Product Code:** [JWH](/submissions/OR/subpart-d%E2%80%94prosthetic-devices/JWH.md)
- **Decision Date:** Mar 29, 2019
- **Decision:** SESE
- **Submission Type:** Traditional
- **Regulation:** 21 CFR 888.3560
- **Device Class:** Class 2
- **Review Panel:** Orthopedic
- **Attributes:** Therapeutic

## Intended Use

The Klassic® Knee System is intended for prosthetic replacement of the following: - · Patient conditions of non-inflammatory degenerative joint disease (NIDID): avascular necrosis and osteoarthritis - · Patient conditions of inflammatory joint disease (IJD): rheumatoid arthritis - · Patients with failed previous surgery where pain, deformity, or dysfunction persists - · Correctable varus-valgus deformity and moderate flexion contracture - · Revision of a previously failed knee arthroplasty - · Patients who require a total knee replacement The Klassic® Knee System is indicated for cemented use only, except for the Klassic Femur, Porous, and the Klassic Tibial Baseplate, Porous, which are indicated for cementless use.

## Device Story

Klassic Knee System is a semi-constrained knee prosthesis designed to restore knee joint biomechanics. Subject components include posterior stabilizing (PS) femur, femoral pegs, and tibial inserts (standard and E-Link poly). Used by orthopedic surgeons in clinical settings for total knee arthroplasty. Components are available in various sizes/thicknesses to match patient anatomy. Device functions as a mechanical replacement for diseased or damaged knee joints. Benefits include pain relief and restoration of joint function. Substantial equivalence established via engineering analysis and mechanical testing.

## Clinical Evidence

Bench testing only. Engineering analysis and mechanical testing performed, including modular peg strength, stability, contact stress, range of motion, knee simulator wear, tibial insert post fatigue, modular disassembly, and patella/femoral subluxation/stress. Compliance with LAL testing per AAMI ST-72.

## Technological Characteristics

Semi-constrained knee prosthesis; metal/polymer construction. Includes PS-Post femur, femoral pegs, and tibial inserts (standard and E-Link poly). Cemented and cementless options available. Compliant with AAMI ST-72 for LAL testing.

## Regulatory Identification

A knee joint patellofemorotibial polymer/metal/polymer semi-constrained cemented prosthesis is a device intended to be implanted to replace a knee joint. The device limits translation and rotation in one or more planes via the geometry of its articulating surfaces. It has no linkage across-the-joint. This generic type of device includes prostheses that have a femoral component made of alloys, such as cobalt-chromium-molybdenum, and a tibial component or components and a retropatellar resurfacing component made of ultra-high molecular weight polyethylene. This generic type of device is limited to those prostheses intended for use with bone cement (§ 888.3027).

## Predicate Devices

- Klassic® Knee System ([K112906](/device/K112906.md))
- Klassic® Knee System-Tibial Stem Extensions ([K140942](/device/K140942.md))
- Klassic® Knee Sombrero Patella ([K150105](/device/K150105.md))
- Klassic® Knee System - Tibial Inserts, 18mm ([K153075](/device/K153075.md))
- Klassic® Knee System - Femur, Nonporous size 7 ([K153310](/device/K153310.md))
- Klassic® Knee System All Poly Tibia ([K162422](/device/K162422.md))
- Klassic® Knee System Tibial Inserts with E-Link® Poly ([K180159](/device/K180159.md))

## Submission Summary (Full Text)

> This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com.
>
> Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/).

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image contains two logos. On the left is the Department of Health & Human Services logo. On the right is the FDA (U.S. Food & Drug Administration) logo. 

March 29, 2019

Total Joint Orthopedics, Inc. Chris Weaber Product Development, Regulatory Manager 1567 E. Stratford Avenue Salt Lake City, Utah 84106

## Re: K183596

Trade/Device Name: Klassic Knee System - Klassic Knee PS-Post Femur: Klassic Knee Tibial Insert, PS-Post, Std Poly; Klassic Knee Tibial Insert, PS-Post, E-Link Poly Regulation Number: 21 CFR 888.3560 Regulation Name: Knee Joint Patellofemorotibial Polymer Semi-Constrained Cemented Prosthesis Regulatory Class: Class II Product Code: JWH, MBH Dated: December 21, 2018 Received: December 21, 2018

Dear Chris Weaber:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal

{1}------------------------------------------------

statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/CombinationProducts/GuidanceRegulatoryInformation/ucm597488.html; good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803). please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely,

Peter G. Allen -S

Digitally signed by Peter G. Allen -S Date: 2019.03.29 17:00:22 -04'00'

FOR Mark N. Melkerson Director Division of Orthopedic Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

# Indications for Use

510(k) Number (if known) K183596

Device Name Klassic® Knee System

Indications for Use (Describe)

The Klassic® Knee System is intended for prosthetic replacement of the following:

- · Patient conditions of non-inflammatory degenerative joint disease (NIDID): avascular necrosis and osteoarthritis
- · Patient conditions of inflammatory joint disease (IJD): rheumatoid arthritis
- · Patients with failed previous surgery where pain, deformity, or dysfunction persists
- · Correctable varus-valgus deformity and moderate flexion contracture
- · Revision of a previously failed knee arthroplasty
- · Patients who require a total knee replacement

The Klassic® Knee System is indicated for cemented use only, except for the Klassic Femur, Porous, and the Klassic Tibial Baseplate, Porous, which are indicated for cementless use.

| Type of Use (Select one or both, as applicable) |
|-------------------------------------------------|
|-------------------------------------------------|

X Prescription Use (Part 21 CFR 801 Subpart D)

Over-The-Counter Use (21 CFR 801 Subpart C)

### CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

#### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

# 510(k) Summary

| Manufacturer:      | Total Joint Orthopedics, Inc.<br>1567 E. Stratford Avenue<br>Salt Lake City, UT 84106<br>Phone: 801.486.6070<br>Fax: 801.486.6117                                                                                         |
|--------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Contact:           | Mr. Chris Weaber<br>Product Development, Regulatory Manager                                                                                                                                                               |
| Prepared By:       | Musculoskeletal Clinical Regulatory Advisers, LLC<br>1050 K Street, NW, Suite 1000<br>Washington, DC 20001<br>Phone: 202.552.5800<br>Fax: 202.552.5798                                                                    |
| Date Prepared:     | December 21, 2018                                                                                                                                                                                                         |
| Device Trade Name: | Klassic® Knee System - Klassic Knee PS-Post Femur;<br>Klassic Knee Tibial Insert, PS-Post, Std Poly; Klassic Knee<br>Tibial Insert, PS-Post, E-Link Poly                                                                  |
| Common Name:       | PS Femur, PS Inserts                                                                                                                                                                                                      |
| Classifications:   | 21 CFR 888.3560 – Knee joint patellofemorotibial<br>polymer/metal/polymer semi-constrained cemented<br>21 CFR 888.3565 - Knee joint patellofemorotibial metal/<br>polymer porous-coated uncemented prosthesis<br>Class II |
| Product Codes:     | JWH, MBH                                                                                                                                                                                                                  |

## Indications for Use:

The Klassic® Knee System is intended for prosthetic replacement in treatment of the following:

- o Patient conditions of non-inflammatory degenerative joint disease (NIDJD): avascular necrosis and osteoarthritis
- Patient conditions of inflammatory joint disease (IJD): rheumatoid arthritis
- Patients with failed previous surgery where pain, deformity, or dysfunction persists ●
- Correctable varus-valgus deformity and moderate flexion contracture
- Revision of a previously failed knee arthroplasty
- Patients who require a total knee replacement .

The Klassic® Knee System is indicated for cemented use only, except for the Klassic Femur, Porous, and the Klassic Tibial Baseplate, Porous, which are indicated for cementless use.

{4}------------------------------------------------

### Device Description:

The Klassic® Knee System employs prostheses designed to help surgeons restore knee joint biomechanics intra-operatively. The purpose of this 510(k) is to add the posterior stabilizing Klassic® Knee Femur, PS-Post; Klassic Femoral Pegs; and the Klassic® Tibial Insert, PS-Post with Standard Poly; and the Klassic® Tibial Insert, PS-Post with E-Link® Poly; to the Klassic Knee System. The subject femoral and tibial components are available in various sizes and thicknesses to match patient anatomy.

### Predicate Devices:

The modified Klassic® Knee System is substantially equivalent to the predicate Klassic® Knee System (K112906), Klassic® Knee System-Tibial Stem Extensions (K140942), Klassic® Knee Sombrero Patella (K150105), Klassic® Knee System - Tibial Inserts, 18mm (K153075), Klassic® Knee System - Femur, Nonporous size 7 (K153310), Klassic® Knee System All Poly Tibia (K162422), and Klassic® Knee System Tibial Inserts with E-Link® Poly (K180159) with respect to indications, design, material and function.

### Substantial Equivalence:

Engineering analysis and testing included Modular Peg Strength Analysis, Femoral/Tibial Insert Stability Characteristics and Femur/Tibial Insert Contact Stress Evaluation, Range of Motion, Knee Simulator Wear, Tibial Insert Post Fatigue, Tibial Insert Modular Disassembly, Patella/Femoral Subluxation and Patella/Femoral Surface Stress. All results met the predetermined acceptance criteria and demonstrate that the modified Klassic Knee System is substantially equivalent to the identified legally marketed predicate devices. Additionally, the Klassic® Knee System is in compliance with LAL testing requirements for orthopedic implants per AAMI ST-72 testing.

---

**Source:** [https://fda.innolitics.com/submissions/OR/subpart-d%E2%80%94prosthetic-devices/JWH/K183596](https://fda.innolitics.com/submissions/OR/subpart-d%E2%80%94prosthetic-devices/JWH/K183596)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com
